In the laboratory, fluorescent CNT composites were exposed in vitro to PSMA+ HCT-116 LNCaP prostate cancer cells, PSMA CaCo-2 colon cancer cells, and PSMA human peripheral monocytes and lymphocytes. This evidence concerns the gene FOLH1 and prostate carcinoma.